What cephalosporin regimen is recommended for treating an uncomplicated urinary tract infection in a healthy adult male?

Cephalosporin Treatment for UTI in Men

For uncomplicated UTI in men, cephalosporins are NOT first-line agents due to insufficient evidence for optimal duration, but when used, first-generation cephalosporins (cephalexin 500 mg twice daily) are preferred over third-generation agents to minimize collateral damage, particularly Clostridioides difficile infection risk. 1

Critical Context: UTI in Men is Complicated by Definition

The 2024 EAU guidelines explicitly classify "urinary tract infection in males" as a complicated UTI (cUTI) 2. This is crucial because:

• Men inherently have anatomical factors (longer urethra, prostate) that complicate infections
• Prostatitis cannot be reliably excluded in many cases
• Treatment duration should be 7-14 days (14 days when prostatitis cannot be excluded) 2

Evidence Gaps for Cephalosporins in Male UTI

The 2024 JAMA guidelines state there is "not enough evidence to provide a clear recommendation for duration of treatment" for β-lactams in adult cystitis 1. For pyelonephritis, β-lactams require 7 days of treatment 1, but this evidence comes primarily from studies in women.

When Cephalosporins Are Appropriate

First-Generation Cephalosporins (Preferred)

• Cephalexin 500 mg twice daily for 7-14 days
• Achieves excellent urinary concentrations 3
• 92.5% susceptibility against common uropathogens (E. coli, Klebsiella, Proteus) 4
• 2.44-fold lower risk of hospital-onset C. difficile compared to ceftriaxone 4
• Comparable efficacy to traditionally first-line agents for non-ESBL Enterobacteriaceae 3

Third-Generation Cephalosporins (Limited Role)

For oral therapy in pyelonephritis requiring cephalosporin:

• Cefpodoxime 200 mg twice daily for 10 days 2
• Ceftibuten 400 mg once daily for 10 days 2
• Must give initial IV ceftriaxone dose when using oral third-generation agents 2

For IV therapy (severe infection/hospitalization):

• Ceftriaxone 1-2 g daily (higher dose recommended) 2
• Cefotaxime 2 g three times daily 2

Recommended Approach

For Lower UTI (Cystitis-like Presentation):

1. First choice: Nitrofurantoin (spares broader-spectrum agents) 1
2. If cephalosporin needed: Cephalexin 500 mg twice daily for 14 days (given male sex = complicated UTI)
3. Avoid cefdinir despite common use—20.7% treatment failure at 14 days vs 11.8% for cephalexin 5

For Upper UTI (Pyelonephritis/Febrile):

1. First-line: Fluoroquinolone or TMP/SMX (if local resistance <10%) 1, 2
2. If cephalosporin required:
   • Outpatient: Cefpodoxime 200 mg twice daily × 10 days with initial IV ceftriaxone dose 2
   • Inpatient: IV ceftriaxone 2 g daily × 7 days 1, 2

Critical Pitfalls

• Do NOT use cephalosporins as first-line for uncomplicated cystitis—nitrofurantoin is superior for antimicrobial stewardship 1
• Do NOT use cefdinir for UTI despite its popularity—poor urine penetration and higher failure rates 5
• Do NOT use third-generation cephalosporins empirically unless treating pyelonephritis or high resistance risk—doubles C. difficile risk 4
• Do NOT treat male UTI for 3-5 days—minimum 7 days, preferably 14 days when prostatitis cannot be excluded 2
• Always obtain urine culture before treatment in men—this is a complicated UTI requiring tailored therapy 2

Resistance Considerations

• Cefazolin/cephalexin susceptibility testing now uses updated CLSI/USCAST criteria, improving reported susceptibility rates 3
• For ESBL-producing organisms, oral cephalosporins are inadequate—consider IV carbapenems or novel β-lactam/β-lactamase inhibitor combinations 2, 6
• Local resistance patterns must guide empiric choices—if E. coli resistance to first-generation cephalosporins exceeds 10-20%, alternative agents are needed 1, 2